NASDAQ: MDGL · Biotechnology
Over the past week, Madrigal Pharmaceuticals (MDGL) saw 10 mentions across Reddit, X and news, and the read is an Adanos Buy. The crowd averages 63% bullish but is deeply split: News runs 100% bullish while X sits at just 25%. Wall Street is more constructive, with 15 of 17 analysts rating MDGL a buy.
There is little buzz around MDGL this week and little agreement on direction, which is why it reads as a Buy.
Wall Street’s 88% buy share sits next to a crowd that ranges from X at 25% to News at 100%. No other tracker puts the two side by side.
Across 17 analysts the consensus is a Strong Buy: 15 buy calls against 0 sell, with an average 12-month price target of $678.06.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits above the neutral line, momentum is mixed and the 2 sources disagree sharply, so the read is a Buy.
Analysts sit 25 points above the crowd average of 63%, the professionals are more constructive than retail. The split is inside the crowd: News reads 100% bullish while X sits at 25%, a 75-point spread that single-source trackers miss.
Over the 30-day window, Madrigal Pharmaceuticals (MDGL) buzz held subdued around 23.6 while the price drifted up 6.0% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 248K shares. Over the last 7 trading days, MDGL held roughly flat. Buzz activity in the recent week averaged 23.8 and was relatively stable, swinging between 19.1 and 27.6. Recent volume is running below the 30-day average, pointing to quieter participation. Daily crowd sentiment leaned bullish on 8 of the 17 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Reddit data for this stock this week.
No Polymarket data for this stock this week.
Query sentiment for MDGL and 2001+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live MDGL sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Sep 04, 2026.
| Adanos signal | Buy |
|---|---|
| Analyst consensus | Strong Buy (15 / 2 / 0) |
| Crowd bullish (7d) | 63% |
| Avg price target | $678.06 |
| Most bullish source | News, 100% |
| Most bearish source | X, 25% |
| Sentiment spread | 75 pts |
| Mentions (7d) | 10 |
| Market cap | $12.54B |
| P/E · Forward P/E | n/a · 82.0 |
| EPS · Beta | -$13.89 · -1.0 |
| Revenue (TTM) | $1.28B · -25% margin |
| Industry | Biotechnology |
Based on aggregated sentiment from X and News sources, Madrigal Pharmaceuticals (MDGL) currently carries an Adanos buy signal with 89/100 conviction. The current cross-source average reads 63% bullish across 2 active sources. Those sources contribute 10 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
The crowd reads bullish on Madrigal Pharmaceuticals (MDGL), averaging 63% bullish across 2 tracked sources over the last 7 days. The two ends of the range are News at 100% bullish and X at 25%, a 75-point spread. On the professional side, 15 of 17 analysts rate MDGL a buy.
Of the 17 analysts covering Madrigal Pharmaceuticals (MDGL), 15 rate it a buy, 2 a hold and 0 a sell, for a strong buy consensus. The average price target is $678.06. That puts the street ahead of the crowd, which averages 63% bullish.
Madrigal Pharmaceuticals (MDGL)'s cross-source average is bullish at 63% bullish. Source readings are split: 1 source leans bullish and 1 source leans bearish. News reads 100% bullish and x coverage is the most negative at 25% bullish. The combined signal points to broad buy-side pressure with 89/100 conviction.
The cross-source average is bullish for Madrigal Pharmaceuticals (MDGL) at 63% bullish. Source readings are split: 1 source leans bullish and 1 source leans bearish. The most bearish reading is x at 25% bullish. The buy signal carries 89/100 conviction.
News is the dominant discussion channel with 6 mentions (60% of total volume). X contributes 4 mentions. The cross-source average is bullish at 63% bullish. Source readings are split: 1 source leans bullish and 1 source leans bearish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. MDGL's buy signal at 89/100 conviction reflects a bullish cross-source average at 63% bullish. Source readings are split: 1 source leans bullish and 1 source leans bearish. It is a research shortcut, not financial advice.
The MDGL sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Buy signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key